Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Itopride - AbbVie

Next Previous
X
Search
Drug Profile

Itopride - AbbVie

Alternative Names: Ganaton; HSR 803; Itax

Latest Information Update: 25 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Abbott Japan
  • Developer Abbott Japan; AbbVie; Astellas Pharma; Axcan Pharma
  • Class Antiulcers; Benzamides; Benzyl compounds; Gastrokinetics; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Gastritis; Gastrointestinal disorders
  • Phase III Non-ulcer dyspepsia
  • Discontinued Diabetic gastroparesis; Postoperative ileus

Most Recent Events

  • 28 Feb 2024 Phase-III clinical trials in Non-ulcer dyspepsia in Armenia, Malaysia (PO, Controlled release) (NCT06217393)
  • 19 Jan 2024 Abbott plans a phase III trial for functional dyspepsia (In adults, In the elderly) (PO, Tablet) in January 2024 (NCT06217393)
  • 13 Feb 2017 CTP push 281683 - Trial completion info already updated; Minor updates done in KDM

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top